The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions

Chest

Volumn 111, Issue 6, 1997, Pages 1583-1590

  Raab, Stephen S ^a   Hornberger, John ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost; Desicion analysis; Diagnosis; Lung cancer; Pathology; Probability; Testing

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; ILLNESS BEHAVIOR; LIFE EXPECTANCY; LIFESTYLE; LUNG CANCER; PATIENT ATTITUDE; PRIORITY JOURNAL; PROBABILITY;

EID: 0030947385     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1583     Document Type: Article

References (37)

1. American Cancer Society. Cancer fact and figures. Atlanta: American Cancer Society, 1995
2. Dail DH, Hammar SP. Pulmonary pathology. 2nd ed. New York: Springer-Verlag, 1994
3. Salazar A, Westcott J. The role of thoracic needle biopsy for the diagnosis and staging of lung cancer. Lung Cancer 1993; 14:99-110
4. Arroliga A, Matthay R. The role of bronchoscopy in lung cancer. Lung Cancer 1993; 14:87-98
5. Johnston WW, Elson C. Cytology of other body sites: respiratory tract. In: Bibbo M, ed. Comprehensive cytopathology. 1st ed. Philadelphia: WB Saunders, 1991; 330-98
6. Mehta AC, Marty CC, Lee FWY. Sputum cytology. Lung Cancer 1993; 14:36-85
7. Coosemans W, Lerut T, Van Raeindouck D. Thorascopic surgery: the Belgian experience. Ann Thorac Surg 1993; 56:621-60
8. Miller J. The present role and future considerations of video-assisted thoroscopy in general thoracic surgery. Ann Thorac Surg 1995; 56:804-06
9. Warner K, Luce B. Cost-benefit and cost-effectiveness analysis in health care: principles, practice and potential. Ann Arbor. Mich: Health Administration Press, 1982; 1-100
10. Barlow PB, Beck JR. The solitary pulmonary nodule: a decision analysis [abstract]. Chest 1985; 88:45S
11. Kunstaetter K, Wolkove N, Kreisman H, et al. The solitary pulmonary nodule: decision analysis. Med Decis Making 1985; 5:61-75
12. Cummings SH, Lillington GA, Richards RJ. Managing solitary pulmonary nodules: the choice of strategy is a 'close call.' Am Rev Respir Dis 1986; 134:453-60
13. Raab SS, Thomas PA, Hornberger JC. The role of sputa in the evaluation of lung lesions. Acta Cytol 1995; 39:1064
14. Kenny RL. Value focused thinking: a path to creative decision making. 1st ed. Cambridge, Mass: Harvard University Press, 1992
15. Kalmeman D, Tversky A. Choices, values, and frames. Am Psychol 1984; 39:341-50
16. Weinstein MC, Kineberg HV. Clinical decision analysis. 1st ed. Philadelphia: WB Saunders, 1980; 12-36
17. National Cancer Institute, Health NIO. Lung Cancer Surveillance. Epidemiology and End Results (SEER) Program. Bethesda, Md: National Institute of Health Press, 1995
18. Mountain C. A new international staging system for lung cancer. Chest 1986; 89:2255-2335
19. Martini N, Bains M, McCormack P, et al. Surgical treatment in non-small cell carcinoma of the lung: the Memorial Sloan-Kettering experience. In: Hoogstraten B, Addis BJ, Hansen HH, et al eds. Treatment of lung tumors, Heidelburg: Springer-Verlag, 1987; 111-32
20. Martini N. Operable lung cancer. CA Cancer J Clin 1993; 43:201-14
21. Greenberg S, Fraire A, Kinner B, et al. Tumor cell type versus staging in the prognosis of carcinoma ol the lung. Pathol Annu 1995; 2:398-405
22. Shields T. Surgical therapy for carcinoma of the lung. Lung Cancer 1993; 14-47:121-47
23. Nathan M. Management of solitary pulmonary nodules: an organized approach based on growth rate and statistics. JAMA 1994; 227:1141-44
24. Nathan M, Colloing V, Adams R. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1992; 79:221-32
25. National Center for Health Statistics, Public Health Service. Vital statistics of the United States. Life tables (vol 2), section 6. DHHS publication No. (PHS) 88:1147. Washington. DC: US Government Printing Office, 1988: 6-67
26. Ginsberg R, Surgery and small cell lung cancer: an overview. Lung Cancer 1989; 5:232-36
27. Donovan K, Sanson-Fisher RW, Redman S. Measuring quality of life in cancer patients. J Clin Oncol 1989; 7:959-68
28. Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev 1993; 19(suppl A):85-96
29. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989; 28:299-308
30. Carr-Hill RA. Background material for the workshop on QALYs. Soc Sci Med 1989; 3:469-77
31. Hollen PJ, Gralla HJ, Kris MG, et al. Quality of life assessment in individuals with lung cancer: testing the lung cancer symptom scale (LCSS). Eur J Cancer 1993: 29A(Suppl 1):S51-58
32. Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Cancer 1994; 73:2087-98
33. Schmitt R. Quality of life issues in lung cancer: new symptom management strategies. Chest 1993; 103:51S-5S
34. Howard RA. The science of decision-making. In: Howard RA, Matheson JE, eds. The principles and applications of decision analysis (vol 1): general collection. Menlo Park, Calif: Strategic Decisions Group, 1990; 161-76
35. Tversky A, Thaler RH. Preference reversals. J Econom Perspec 1990; 4:201-11
36. Ellsberg D. Risk, ambiguity, and the savage axioms. Q J Econ 1961; 75:643-69
37. Kasper JF, Mulley AG. Wennberg JE. Developing shared decision making programs to improve quality of health care. Qnal Rev Bull 1992; 18:183-90